Aclarion(us:ACON)

    0.1276

    +2.16%

    Updated on 2024-12-23

    Open:0.1290
    Close:0.1276
    High:0.1347
    Low:0.1211
    Pre Close:0.1249
    Volume:645252.00
    Amount:82412.45
    Turnover:6.18%
    Shares:10.44M
    MarketCap:1.33M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30123292984.01%543
    2024-03-31112725933.81%254
    2023-12-3111388400.29%243
    2023-09-3015336490.41%228
    2023-06-30146157297.51%731
    2023-03-3181741162.21%320
    2022-12-319318290.40%015
    2022-09-3091582712.02%710
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Virtu Financial Llc1151831.61%115183
    2024-03-31Captrust Financial Advisors984361.38%68784231.97%
    2024-03-31Hrt Financial Lp286390.40%270011648.41%
    2024-03-31Citadel Advisors Llc248490.35%231201337.19%
    2024-03-31Tower Research Capital Llc (Trc)53720.08%4542547.23%
    2024-03-31Bank Of America Corp /De/1000.00%100
    2024-03-31Wells Fargo & Company/Mn140.00%11366.67%
    2024-03-31State Street Corp0-988
    2024-03-31Two Sigma Securities, Llc0-1440
    2024-03-31Whittier Trust Co0-603

    About

    Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
    Address:8181 Arista Place,Suite 100

    Market Movers